CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue

• Gabrielle Stack,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Emma Jones,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Morgan Marsden,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Maria A. Stacey,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Robert J. Snelgrove,

  Affiliation Leukocyte Biology Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom

  ⨯
• Paul Lacaze,

  Affiliation Division of Pathway Medicine and Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Laura C. Jacques,

  Current address: Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Simone M. Cuff,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Richard J. Stanton,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Awen M. Gallimore,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Tracy Hussell,

  Affiliation Manchester Collaborative Centre for Inflammation Research (MCCIR), University of Manchester, Manchester, United Kingdom

  ⨯
• Gavin W. G. Wilkinson,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Peter Ghazal,

  Affiliation Division of Pathway Medicine and Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Philip R. Taylor,

  Affiliation Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom

  ⨯
• Ian R. Humphreys

  * E-mail: humphreysir@cardiff.ac.uk

  Affiliations Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom

  ⨯